Introduction

Risk-based inspection models are regulatory systems that determine which facilities should be inspected, how frequently inspections should occur, and how closely compliance should be examined according to the level of risk they pose. In biotechnology, these models may be used for laboratories, pharmaceutical manufacturing facilities, genetically modified organism (GMO) research sites, and facilities handling hazardous biological materials.

Transparency is essential because inspection scores and risk classifications can influence regulatory scrutiny, business operations, and public confidence. A transparent system should explain its legal basis, relevant risk factors, inspection procedures, and available review mechanisms. It should also protect legitimate confidential information, including sensitive biosafety and commercial data.

In India, risk-based inspections operate in several regulatory sectors. For biotechnology, the Environment (Protection) Act, 1986, and the 1989 Rules establish biosafety authorities with inspection, monitoring, and enforcement functions. The legal challenge is to balance efficient risk-focused regulation with fairness, accountability, and the right to challenge arbitrary decisions.

Important Case Laws

1. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court considered the regulatory approval of genetically modified mustard (DMH-11) and examined the biosafety framework governing GM organisms. The judgment discussed the functions of the Genetic Engineering Appraisal Committee (GEAC), State Biotechnology Coordination Committees (SBCCs), and District Level Committees (DLCs), including inspection, monitoring, supervision, and enforcement.

The Court highlighted the importance of scientifically sound and transparent risk assessment. It also referred to risk communication as a two-way process involving information-sharing and dialogue with stakeholders. The judgment is relevant because transparent inspection models should make regulatory responsibilities clear and allow scrutiny of how risk classifications and biosafety decisions are reached. The judges delivered separate opinions and differed on the approval of GM mustard; the judgment should not be presented as a unanimous approval.

Indian Kanoon

2. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (1999) 2 SCC 718

The Supreme Court emphasised the need for scientific expertise in environmental decision-making where risks are technically complex or uncertain. The Court supported referring scientific questions to specialised expert bodies and allowing the parties an opportunity to present evidence and objections.

This case supports transparent inspection governance by analogy: risk-based inspection findings should be grounded in scientific evidence, and regulated entities should have a fair opportunity to understand and contest material findings.

ELAW: Environmental Law Alliance Worldwide+1

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu, (2001) 2 SCC 62

In the subsequent proceedings, the Supreme Court relied on further expert reports and upheld the need to prevent pollution of drinking-water reservoirs. The decision reinforces the importance of evidence-based regulatory decisions and expert review in environmental matters.

It is relevant to inspection transparency because inspection priorities and enforcement decisions should be supported by a reliable record, especially where the consequences may affect public health or the environment.

Indian Kanoon+1

Essential Transparency Standards

A fair risk-based inspection model should provide:

Published criteria: Explain the risk factors used to determine inspection frequency and intensity.

Consistent procedures: Use standard inspection checklists and documented methods.

Reasoned findings: Explain the factual basis for violations and corrective directions.

Fair opportunity: Allow regulated entities to respond to material findings and seek review.

Public accountability: Publish suitable summaries of inspection outcomes and enforcement actions, while protecting legitimate confidential or sensitive information.

Risk-based inspection does not mean that low-risk facilities are immune from inspection. Random checks, complaint-based inspections, and emergency inspections remain important to prevent manipulation of risk scores or concealment of hazards.

Conclusion

Risk-based inspection models can improve regulatory efficiency by directing resources toward facilities posing greater risks. However, their legitimacy depends on transparency, scientific justification, consistency, and fair procedures. Gene Campaign provides a direct connection to GMO regulatory oversight and transparent biosafety risk analysis. A.P. Pollution Control Board v. Nayudu supports expert assessment and evidence-based decision-making. Together, these cases show that risk-based inspection should be accountable and reviewable, rather than an opaque system in which unexplained risk scores determine regulatory treatment.

Indian Kanoon+2